Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management
This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
Adults (≥21 years) admitted to the burn unit with thermal burns ≥20% TBSA and <... [+3]
Pre-existing coagulopathy or anticoagulant therapy prior to injury. [+3]